What is the BlueInvest Project Pipeline?
See our showcase of innovative projects and entrepreneurs who are shaping the Blue Economy.
Projects consist of innovative, scalable and sustainable business ventures from traditional and emerging sectors of the maritime economy.
The graphs below provide an overview of the country distribution, sector, and TRL of projects currently listed in the BlueInvest Project Pipeline.
Selection Criteria:
Your company is EU-based or from an eligible sea basin region (Georgia, Turkey, Ukraine, Moldova, Montenegro, Albania, Bosnia-Herzegovina, North Macedonia, Serbia, Turkey, Israel, Egypt, Tunisia, Algeria, Morocco, Lebanon, Syria, Libya, Mauritania, United Kingdom, or Norway)
Your project TRL is 4 or higher
Your project sector is in one of the 10 blue economy sectors identified for this initiative
Your solution has a clear sustainable impact on the blue economy
Your project is looking for investment
Project Country
Country in which the project is being developed and / or implemented.
Project Sector
Main blue economy sector the project relates to.
Project TRL
Current technology readiness level of the project.
This is Seaweed Ltd.
Paul O Connor – Founder and CEO
Paul, a Marine Biologist, has researched the marine environment in Ireland, the United Kingdom, and the Netherlands for a period of ten years. Prior to becoming a Marine Biologist, Paul worked as European Sales & Development manager for a leading software distribution company.
Tony Richardson – Chairman and Investor
Tony has worked in Life Science for 25 years. He co-founded Alltracel Pharmaceuticals in 1996. Alltracel was a medical device business focused on the wound care and oral care sectors. Alltracel listed on the London Stock Exchange in 2001 and in 2008 the company was sold to a US company. In 2010, Tony founded Venn Life Science, a drug development support company. Venn also listed on the London Stock Exchange, and in 2019 was sold to a European CRO. Tony has extensive experience in capital-raising, M&A, product development, and commercialisation in international markets.
The global nutraceuticals market is projected to reach €642 billion by 2027, growing at a compound rate more than 8%. The plant-based protein section of that market was valued at €18.5 billion in 2019 and is projected to reach €40 billion by 2025. The major food ingredient companies are all committed to producing healthier foods. Unilever has publicly communicated a focus on five fortifiers: iodine, iron, zinc, Vitamin A and Vitamin D – all available from marine algae. It is also reported that 40% of global food companies have dedicated product development teams to develop and sell plant-based alternatives to meat and dairy.
We have developed a novel technology to extract protein, alginate and fibre in a zero-pollution solution that is both low energy and low cost. Current extraction methods result in long extraction times, low extraction yields and use significant amounts of solvents which can lead to issues relating to environmental pollution. Due to the non-abrasive nature of this process, the full suite of marine phenolics can be extracted and utilised. Our first product is a protein extract with high bioactivity that can be used across a wide range of products, from energy bars to yoghurts, vegan alternatives to fish and chicken.